{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:19:42Z","timestamp":1793513982973,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","award":["23-010347"],"award-info":[{"award-number":["23-010347"]}],"id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.mayocp.2025.01.026","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:20:50Z","timestamp":1754407250000},"page":"106-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Tumor Burden and Cardiac Factors on Survival After Valve Surgery for Carcinoid Heart Disease"],"prefix":"10.1016","volume":"101","author":[{"given":"Tedy","family":"Sawma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartzell V.","family":"Schaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokce Belge","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defne Gunes","family":"Ergi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Todd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Tuba","family":"Kendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Allen","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius A.","family":"Thiels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorvardur R.","family":"Halfdanarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Pellikka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-1478","authenticated-orcid":false,"given":"Juan A.","family":"Crestanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mayocp.2025.01.026_bib1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumors","volume":"340","author":"Kulke","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2025.01.026_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-6196(11)62328-8","article-title":"Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years","volume":"77","author":"Simula","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mayocp.2025.01.026_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/endrev\/bnad035","article-title":"What is carcinoid syndrome? A critical appraisal of its proposed mediators","volume":"45","author":"Mulders","year":"2024","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2025.01.026_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13060","article-title":"Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)","volume":"34","author":"Hofland","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.01.026_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mayocp.2025.01.026_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.01.026_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.mayocp.2025.01.026_bib8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.mayocp.2025.01.026_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/EC-16-0092","article-title":"Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?","volume":"6","author":"Zappa","year":"2017","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.mayocp.2025.01.026_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jtcvs.2018.09.025","article-title":"Improving outcome of valve replacement for carcinoid heart disease","volume":"158","author":"Nguyen","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"20","key":"10.1016\/j.mayocp.2025.01.026_bib11","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jacc.2015.09.014","article-title":"Early and late outcomes of surgical treatment in carcinoid heart disease","volume":"66","author":"Connolly","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2025.01.026_bib12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2025.01.026_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.01.026_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ehjci\/jeab049","article-title":"A 33-year follow-up after valvular surgery for carcinoid heart disease","volume":"23","author":"Bergsten","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.mayocp.2025.01.026_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1677\/ERC-09-0319","article-title":"Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas","volume":"18","author":"Hentic","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2025.01.026_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MEG.0b013e328359d1a6","article-title":"Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors","volume":"25","author":"Palazzo","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.mayocp.2025.01.026_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1055\/a-2159-5548","article-title":"Bone metastases in patients with pancreatic NETs: prevalence and prognosis","volume":"55","author":"Mathew","year":"2023","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.mayocp.2025.01.026_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12020-022-03160-2","article-title":"Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors","volume":"78","author":"Leli\u00e8vre","year":"2022","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.mayocp.2025.01.026_bib19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3892\/ol.2012.622","article-title":"Skeletal metastasis of carcinoid tumors: two case reports and review of the literature","volume":"3","author":"Hori","year":"2012","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.mayocp.2025.01.026_bib20","first-page":"184","article-title":"Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism","volume":"44","author":"Meijer","year":"2003","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.mayocp.2025.01.026_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/EC-14-0119","article-title":"Bone metastases and skeletal-related events from neuroendocrine tumors","volume":"4","author":"Van Loon","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.mayocp.2025.01.026_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102168","article-title":"Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: a systematic review and meta-analysis","volume":"94","author":"Garcia-Torralba","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.mayocp.2025.01.026_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1072-7515(00)00222-2","article-title":"Hepatic neuroendocrine metastases: does intervention alter outcomes?","volume":"190","author":"Chamberlain","year":"2000","journal-title":"J Am Coll Surg"},{"issue":"7","key":"10.1016\/j.mayocp.2025.01.026_bib24","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s002689900138","article-title":"Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation","volume":"20","author":"Dousset","year":"1996","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2025.01.026_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00268-001-0014-7","article-title":"Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery","volume":"25","author":"Jaeck","year":"2001","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.mayocp.2025.01.026_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jamcollsurg.2011.03.029","article-title":"Hepatic resection for the carcinoid syndrome in patients with severe carcinoid heart disease: does valve replacement permit safe hepatic resection?","volume":"213","author":"Lillegard","year":"2011","journal-title":"J Am Coll Surg"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619625001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:31:41Z","timestamp":1776288701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619625001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0025619625001107"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.01.026","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Tumor Burden and Cardiac Factors on Survival After Valve Surgery for Carcinoid Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}